Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Align Technology (ALGN)

Align Technology Q1 2025 revenue falls 1.8% to $979.3 million; EPS $1.27

Negative Impact 3 of 5 earnings Written later

Align Technology reported first quarter 2025 results, with total revenue of $979.3 million, down 1.8% from a year earlier, and diluted EPS of $1.27, down from $1.39. The company said results were in line with its outlook and guided second-quarter 2025 revenue to $1,050 million to $1,070 million, and fiscal 2025 revenue growth to 3.5% to 5.5% at current spot rates.

Key points

  • Q1'25 revenue was $979.3 million, down 1.8% year-over-year; foreign exchange reduced revenue by about $31.1 million year-over-year.
  • Q1'25 GAAP net income was $93.2 million, or $1.27 per diluted share, versus $1.39 a year earlier; non-GAAP diluted EPS was $2.13.
  • Clear Aligner volume rose 6.2% year-over-year to 642.3 thousand cases, while Clear Aligner revenue fell 2.5% to $796.8 million.
  • Guidance: Q2'25 revenue of $1,050 million to $1,070 million; fiscal 2025 GAAP operating margin about 2 points above 2024, and capital expenditures of $100 million to $150 million.

The filing

CompanyAlign Technology (ALGN)
Form8-K, current report
Filed with the SECApr 30, 2025, 4:06 PM ET
Accession number0001097149-25-000028

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:12 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 30, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.